ATRX and cancer: ATRX downregulation is very often seen in ALT cancer cells, and current knowledge indicates that ATRX depletion may be linked to epigenetic changes (such as the reduction of the trimethylated form of both H3K9 and H4K20) in telomeric regions that favor chromatin relaxation and thus the onset of HR [48].